Singular Genomics Corp (OMIC) Cash per Single Share

singulargenomics.com - graphic logo of issuer OMIC

Can the "razor and blade" model ensure cash flow through the sale of consumables? Cash per share provides the answer, where the current metric is 44.89. Singular Genomics Systems (OMIC) is developing partnerships with laboratories for precise genome analysis. However, expansion is slowing due to pricing pressure from market leaders on the compact sequencing systems segment.

Singular Genomics Systems Inc (OMIC) Cash per Share: for the period 07/04/2022 - 03/01/2025

Analytical breakdowns for Singular Genomics (OMIC)

- market price and analyst price targets:
- cash availability and cash flow indicators:
Comprehensive company analysis:Singular Genomics Systems
Manufactured product of singulargenomics.com

This metric serves as a key indicator of the issuer's financial stability during periods of market volatility. The metric is calculated by dividing the total volume of liquid cash by the number of shares outstanding. By analyzing the cash level per share, an investor determines the business's actual margin of safety. For Singular Genomics Systems (OMIC), such reserves are critically important, as they ensure coverage for the high costs of specialized transportation for precision DNA sequencing equipment.

Competing companies

TEM (Tempus AI Inc) - Cash Calculated per Single Share|Cash per Share QGEN|IONS - Cash on Hand per Share|Cash Funds per Share Repligen RGEN|RNA: Cash Funds per Single Share|CRSP: Cash per Single Share|GeneDx Corp (WGS) - Cash per Single Share|RARE: Cash per Share|BEAM - Cash Funds Calculated per Share|SRPT (Sarepta Therapeutics) - Cash per Share|Cash per Single Share Twist Bioscience Inc (TWST)|Cash per Share TXG|Cash Funds Calculated per Share Intellia|Stoke - Cash per Single Share|BLFS: Cash Funds per Single Share|Wave Life Sciences Corp - Cash per Share|Maze Therapeutics, Inc. (MAZE) - Cash per Single Share|Sionna Therapeutics Inc (SION) - Cash Funds per Share|Cash per Single Share Prime Medicine Corp|Cash Funds per Share tayshagtx.com|QURE - Cash Funds Volume per Share|Cash per Single Share MGTX (MeiraGTx Holdings plc)|REGENXBIO (RGNX) - Cash Funds Volume per Share|Cash per Share SLDB (Solid Biosciences Inc.)|Amount of Cash per Share OCGN|PacBio Corp - Cash per Share|Benitec Biopharma Inc. (BNTC) - Cash per Single Share|DSGN: Cash per Share|Cash Funds per Single Share RCKT|Cash per Single Share FDMT|Cash Funds per Single Share LXEO (Lexeo Therapeutics)|Cash per Share KRRO|Editas Medicine, Inc. - Cash Funds per Single Share|Cash Funds per Share Silence Therapeutics Inc. SLN|Cash per Share ProQR Therapeutics N.V. PRQR|CDXS: Cash per Single Share|Cash Funds Volume per Share Sangamo (SGMO)|NAUT (Nautilus Bio) - Cash per Single Share|MGX - Cash Funds Calculated per Share|DTIL (Precision BioSciences Inc.) - Cash per Share|generationbio.com (GBIO) - Cash Funds Calculated per Share|Cash Funds per Share Boundless Bio Inc (BOLD)|Cash per Share Exicure Inc. (XCUR)|Cash Funds per Share imunon.com IMNN|Cash per Share Phio Pharmaceuticals PHIO|Mustang Bio Inc - Cash per Share|Cash on Hand per Share transcodetherapeutics.com|BNGO: Cash per Share|Cash Funds per Single Share APDN|BLUE (bluebirdbio.com) - Cash per Share|Cash on Hand per Share ImmunoPrecise Antibodies IPA|Cash per Single Share OMGA (omegatherapeutics.com)|RGLS (Regulus Therapeutics Inc.) - Amount of Cash per Share|Cash per Share SYRS (Syros Pharmaceuticals Inc.)|Cash Calculated per Single Share TBIO (Codex DNA)|TCON - Cash Funds per Share|Cash on Hand per Share Unity Biotechnology